Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00587912 · ClinicalTrials.gov registry record

AIDS and Cancer Specimen Bank (ACSB)

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
65
Enrollment target

NCT00587912: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00587912 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00587912 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
65 participants
Enrollment target

Study Summary

The purpose of this study is to obtain clinical specimens from pathologists and physicians involved in the diagnosis and care of patients with AIDS and non-AIDS associated malignancies. The National Cancer Institute has set up a Bank for tissues and biological fluids from HIVpositive and HIV-negative individuals in order to have specimens available for scientists studying malignancies associated with HIV disease.

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 1997-06
Est. Completion 2011-04

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00587912

The ClinicalTrials.gov registry entry for NCT00587912 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00587912 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00587912 about?

NCT00587912 is a clinical study titled "AIDS and Cancer Specimen Bank (ACSB)". The purpose of this study is to obtain clinical specimens from pathologists and physicians involved in the diagnosis and care of patients with AIDS and non-AIDS associated malignancies. The National Cancer Institute has set up a Bank for tissues and biological fluids from HIVpositive and HIV-negati...

What is the current status of trial NCT00587912?

This trial is currently completed. The enrollment target is 65 participants. The study started on 1997-06. Estimated completion is 2011-04.

Who is sponsoring clinical trial NCT00587912?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.